title: Comparison of the in vitro susceptibility of rifaximin versus norfloxacin against multidrug resistant bacteria in a hospital setting. A proof-of-concept study for use in advanced cirrhosis.
authors.affiliation: Department of Clinical Medicine, Miguel Hernández University, Elche, Alicante, Spain Departments of Internal Medicine, Hospital General Universitario, Alicante, Spain.
authors.forename: J M
authors.initials: JM
authors.lastname: Ramos
authors.affiliation: Departments of Microbiology, Hospital General Universitario, Alicante, Spain.
authors.forename: I
authors.initials: I
authors.lastname: Vidal
authors.affiliation: Liver Unit, Hospital General Universitario, Alicante, Spain CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.
authors.forename: P
authors.initials: P
authors.lastname: Bellot
authors.affiliation: CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.
authors.forename: I
authors.initials: I
authors.lastname: Gómez-Hurtado
authors.affiliation: CIBERehd, Instituto de Salud Carlos III, Madrid, Spain Department of Clinical Pharmacology, Hospital General Universitario, Alicante, Spain.
authors.forename: P
authors.initials: P
authors.lastname: Zapater
authors.affiliation: CIBERehd, Instituto de Salud Carlos III, Madrid, Spain Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.
authors.forename: J
authors.initials: J
authors.lastname: Such
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D024901:Drug Resistance, Multiple, Bacterial; D006090:Gram-Negative Bacteria / Q000187:drug effects*; D006094:Gram-Positive Bacteria / Q000187:drug effects*; D006801:Humans; D008103:Liver Cirrhosis / Q000382:microbiology; D008826:Microbial Sensitivity Tests; D009643:Norfloxacin / Q000494:pharmacology*; D012294:Rifamycins / Q000494:pharmacology*; D000078262:Rifaximin
chemical_list: D000900:Anti-Bacterial Agents; D012294:Rifamycins; D000078262:Rifaximin; D009643:Norfloxacin
keywords: ANTIBIOTIC THERAPY; ANTIBIOTICS; CHRONIC LIVER DISEASE